Published in PLoS Pathog on March 13, 2009
Parvovirus glycan interactions. Curr Opin Virol (2014) 0.90
The effect of DNA-dependent protein kinase on adeno-associated virus replication. PLoS One (2010) 0.86
Role of herpes simplex virus ICP0 in the transactivation of genes introduced by infection or transfection: a reappraisal. J Virol (2010) 0.85
Does human bocavirus infection depend on helper viruses? A challenging case report. Virol J (2011) 0.85
Identification of rep-associated factors in herpes simplex virus type 1-induced adeno-associated virus type 2 replication compartments. J Virol (2010) 0.83
Inhibition of herpes simplex virus type 1 replication by adeno-associated virus rep proteins depends on their combined DNA-binding and ATPase/helicase activities. J Virol (2010) 0.81
Adeno-associated virus type 2 modulates the host DNA damage response induced by herpes simplex virus 1 during coinfection. J Virol (2011) 0.81
Transcriptional analysis of the adeno-associated virus integration site. J Virol (2009) 0.79
Adeno-Associated Virus Type 2 Rep68 Can Bind to Consensus Rep-Binding Sites on the Herpes Simplex Virus 1 Genome. J Virol (2015) 0.77
Viral and Cellular Components of AAV2 Replication Compartments. Open Virol J (2013) 0.77
Vaccinia virus as a subhelper for AAV replication and packaging. Mol Ther Methods Clin Dev (2015) 0.76
Impact of the MRN Complex on Adeno-Associated Virus Integration and Replication during Coinfection with Herpes Simplex Virus 1. J Virol (2015) 0.75
Herpes simplex virus type 1/adeno-associated virus hybrid vectors. Open Virol J (2010) 0.75
Cell cycle-dependent expression of AAV2 Rep in HSV-1 co-infections gives rise to a mosaic of cells replicating either AAV2 or HSV-1. J Virol (2017) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol (2004) 36.25
DNA cloning using in vitro site-specific recombination. Genome Res (2000) 10.14
A herpes simplex virus type 1 function continuously required for early and late virus RNA synthesis. Nature (1980) 8.47
Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol (1985) 8.12
Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity. EMBO J (1984) 7.33
Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol (1989) 6.69
ICP0, a regulator of herpes simplex virus during lytic and latent infection. Bioessays (2000) 3.09
A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology (1993) 2.78
Biology of adeno-associated virus. Curr Top Microbiol Immunol (1996) 2.40
Formation of herpes simplex virus type 1 replication compartments by transfection: requirements and localization to nuclear domain 10. J Virol (1997) 1.81
ND10 protein PML is recruited to herpes simplex virus type 1 prereplicative sites and replication compartments in the presence of viral DNA polymerase. J Virol (1998) 1.75
Cooperativity among herpes simplex virus type 1 immediate-early regulatory proteins: ICP4 and ICP27 affect the intracellular localization of ICP0. J Virol (1994) 1.66
Assembly of herpes simplex virus replication proteins at two distinct intranuclear sites. Virology (1997) 1.60
A novel 165-base-pair terminal repeat sequence is the sole cis requirement for the adeno-associated virus life cycle. J Virol (1997) 1.57
A subset of herpes simplex virus replication genes provides helper functions for productive adeno-associated virus replication. J Virol (1991) 1.56
Interaction of the viral activator protein ICP4 with TFIID through TAF250. Mol Cell Biol (1996) 1.56
Adenovirus helper function for growth of adeno-associated virus: effect of temperature-sensitive mutations in adenovirus early gene region 2. J Virol (1980) 1.54
The ICP4 binding sites in the herpes simplex virus type 1 glycoprotein D (gD) promoter are not essential for efficient gD transcription during virus infection. J Virol (1992) 1.51
Modification of some biological properties of HeLa cells containing adeno-associated virus DNA integrated into chromosome 17. J Virol (1992) 1.45
Physical interaction between the herpes simplex virus type 1 immediate-early regulatory proteins ICP0 and ICP4. J Virol (1994) 1.45
Engineered herpes simplex virus DNA polymerase point mutants: the most highly conserved region shared among alpha-like DNA polymerases is involved in substrate recognition. J Virol (1990) 1.41
High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap. Gene Ther (1999) 1.34
Site-specific mutagenesis of a highly conserved region of the herpes simplex virus type 1 DNA polymerase gene. J Virol (1990) 1.32
The carboxyl-terminal domain of RNA polymerase II is phosphorylated by a complex containing cdk9 and infected-cell protein 22 of herpes simplex virus 1. J Virol (2005) 1.30
In vitro excision of adeno-associated virus DNA from recombinant plasmids: isolation of an enzyme fraction from HeLa cells that cleaves DNA at poly(G) sequences. Mol Cell Biol (1988) 1.26
Requirements for activation of the herpes simplex virus glycoprotein C promoter in vitro by the viral regulatory protein ICP4. J Virol (1994) 1.22
The Rep protein of adeno-associated virus type 2 interacts with single-stranded DNA-binding proteins that enhance viral replication. J Virol (2004) 1.17
Helper functions required for wild type and recombinant adeno-associated virus growth. Curr Gene Ther (2005) 1.14
Herpes simplex virus immediate-early proteins ICP0 and ICP4 activate the endogenous human alpha-globin gene in nonerythroid cells. J Virol (1997) 1.10
Rep-dependent initiation of adeno-associated virus type 2 DNA replication by a herpes simplex virus type 1 replication complex in a reconstituted system. J Virol (2001) 1.05
Adeno-associated virus DNA replication complexes in herpes simplex virus or adenovirus-infected cells. J Biol Chem (1979) 1.04
Adeno-associated virus DNA replication is induced by genes that are essential for HSV-1 DNA synthesis. Virology (1990) 1.01
ssDNA-dependent colocalization of adeno-associated virus Rep and herpes simplex virus ICP8 in nuclear replication domains. Nucleic Acids Res (2003) 0.96
Spatial and temporal organization of adeno-associated virus DNA replication in live cells. J Virol (2004) 0.96
Herpes simplex virus type 1 ICP0 protein mediates activation of adeno-associated virus type 2 rep gene expression from a latent integrated form. J Virol (2004) 0.92
Live covisualization of competing adeno-associated virus and herpes simplex virus type 1 DNA replication: molecular mechanisms of interaction. J Virol (2007) 0.90
Role of the herpes simplex virus helicase-primase complex during adeno-associated virus DNA replication. J Virol (2006) 0.89
Rescue of the adeno-associated virus genome from a plasmid vector: evidence for rescue by replication. J Virol (2003) 0.87
Mechanisms of adeno-associated virus genome encapsidation. Curr Gene Ther (2005) 0.86
DNA-dependent oligomerization of herpes simplex virus type 1 regulatory protein ICP4. J Virol (2007) 0.86
Production of recombinant adeno-associated type 5 (rAAV5) vectors using recombinant herpes simplex viruses containing rep and cap. Mol Ther (2002) 0.83
Functional proteomic analysis of human nucleolus. Mol Biol Cell (2002) 3.07
Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Mol Cell Biol (2009) 2.06
Functional interaction between class II histone deacetylases and ICP0 of herpes simplex virus type 1. J Virol (2004) 1.59
Functional roles of the tegument proteins of herpes simplex virus type 1. Virus Res (2009) 1.38
Herpes simplex virus 1 envelopment follows two diverse pathways. J Virol (2005) 1.37
PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication. J Cell Sci (2010) 1.35
Determination of minimum herpes simplex virus type 1 components necessary to localize transcriptionally active DNA to ND10. J Virol (2003) 1.15
A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and -5. Mol Ther (2002) 1.14
Helper functions required for wild type and recombinant adeno-associated virus growth. Curr Gene Ther (2005) 1.14
Deciphering the human nucleolar proteome. Mass Spectrom Rev (2006) 1.11
Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery. Mol Ther (2005) 1.10
N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers. J Neurochem (2010) 1.10
Nucleolin is required for an efficient herpes simplex virus type 1 infection. J Virol (2008) 1.07
Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo. Mol Ther (2005) 1.01
Live visualization of herpes simplex virus type 1 compartment dynamics. J Virol (2008) 1.00
The cellular TATA binding protein is required for rep-dependent replication of a minimal adeno-associated virus type 2 p5 element. J Virol (2005) 0.98
Imaging-guided gene therapy of experimental gliomas. Cancer Res (2007) 0.98
Update on herpesvirus amplicon vectors. Mol Ther (2004) 0.95
Nucleolin interacts with US11 protein of herpes simplex virus 1 and is involved in its trafficking. J Virol (2011) 0.94
Herpes simplex virus type 1 ICP0 protein mediates activation of adeno-associated virus type 2 rep gene expression from a latent integrated form. J Virol (2004) 0.92
Improved Immunological Tolerance Following Combination Therapy with CTLA-4/Ig and AAV-Mediated PD-L1/2 Muscle Gene Transfer. Front Microbiol (2011) 0.91
Live covisualization of competing adeno-associated virus and herpes simplex virus type 1 DNA replication: molecular mechanisms of interaction. J Virol (2007) 0.90
The structures of bovine herpesvirus 1 virion and concatemeric DNA: implications for cleavage and packaging of herpesvirus genomes. Virology (2003) 0.88
HSV-1 amplicon vectors that direct the in situ production of foot-and-mouth disease virus antigens in mammalian cells can be used for genetic immunization. Vaccine (2010) 0.88
Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines. J Infect Dis (2012) 0.87
Infection with herpes simplex type 1-based amplicon vectors results in an IRF3/7-dependent, TLR-independent activation of the innate antiviral response in primary human fibroblasts. J Gen Virol (2009) 0.87
Herpes simplex virus type 1 amplicons and their hybrid virus partners, EBV, AAV, and retrovirus. Curr Gene Ther (2004) 0.87
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors. J Gene Med (2010) 0.87
Rotavirus viroplasm fusion and perinuclear localization are dynamic processes requiring stabilized microtubules. PLoS One (2012) 0.86
Targeted integration of functional human ATM cDNA into genome mediated by HSV/AAV hybrid amplicon vector. Mol Ther (2007) 0.86
Improved packaging system for generation of high-level noncytotoxic HSV-1 amplicon vectors using Cre-loxP site-specific recombination to delete the packaging signals of defective helper genomes. Hum Gene Ther (2003) 0.85
Thymic but not splenic CD8⁺ DCs can efficiently cross-prime T cells in the absence of licensing factors. Eur J Immunol (2011) 0.85
Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity. J Gen Virol (2005) 0.84
Switching on the lights for gene therapy. PLoS One (2007) 0.84
Identification of replication-competent HSV-1 Cgal+ strain signaling targets in human hepatoma cells by functional organelle proteomics. Mol Cell Proteomics (2008) 0.84
Improving rAAV production and purification: towards the definition of a scaleable process. J Gene Med (2004) 0.84
Hepatitis B virus infection enhances susceptibility toward adeno-associated viral vector transduction in vitro and in vivo. Hepatology (2014) 0.83
Phenotypic rescue after adeno-associated virus-mediated delivery of 4-sulfatase to the retinal pigment epithelium of feline mucopolysaccharidosis VI. J Gene Med (2002) 0.83
Identification of rep-associated factors in herpes simplex virus type 1-induced adeno-associated virus type 2 replication compartments. J Virol (2010) 0.83
Four-dimensional visualization of the simultaneous activity of alternative adeno-associated virus replication origins. J Virol (2005) 0.82
Chimeric herpes simplex virus/adeno-associated virus amplicon vectors. Curr Gene Ther (2006) 0.82
Identification of a single amino acid residue which is critical for the interaction between HSV-1 inner tegument proteins pUL36 and pUL37. Virology (2011) 0.82
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer. Liver Int (2011) 0.82
HSV-1 Cgal+ infection promotes quaking RNA binding protein production and induces nuclear-cytoplasmic shuttling of quaking I-5 isoform in human hepatoma cells. Mol Cell Proteomics (2011) 0.82
Inhibition of herpes simplex virus type 1 replication by adeno-associated virus rep proteins depends on their combined DNA-binding and ATPase/helicase activities. J Virol (2010) 0.81
Characterization of antiproliferative and cytotoxic properties of the HSV-1 immediate-early ICPo protein. J Gene Med (2005) 0.81
Cloning of Bovine herpesvirus type 1 and type 5 as infectious bacterial artifical chromosomes. BMC Res Notes (2009) 0.81
HSV as a vector in vaccine development and gene therapy. Hum Vaccin (2008) 0.81
Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons. J Virol Methods (2005) 0.81
HSV-1 amplicon vectors: a promising and versatile tool for gene delivery. Expert Opin Biol Ther (2007) 0.81
Adeno-associated virus type 2 modulates the host DNA damage response induced by herpes simplex virus 1 during coinfection. J Virol (2011) 0.81
Multitracer positron emission tomographic imaging of exogenous gene expression mediated by a universal herpes simplex virus 1 amplicon vector. Mol Imaging (2007) 0.81
HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice. Mol Ther (2012) 0.81
Identification of replication-competent HSV-1 Cgal+ strain targets in a mouse model of human hepatocarcinoma xenograft. J Proteomics (2009) 0.80
Identification of host cell proteins which interact with herpes simplex virus type 1 tegument protein pUL37. Biochem Biophys Res Commun (2011) 0.80
Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector. Gene Ther (2007) 0.80
Identification of a replication-defective herpes simplex virus for recombinant adeno-associated virus type 2 (rAAV2) particle assembly using stable producer cell lines. J Gene Med (2004) 0.80
HSV as a vector in vaccine development and gene therapy. Adv Exp Med Biol (2009) 0.80
Herpes simplex virus type 1 amplicon vector-mediated gene transfer to muscle. Hum Gene Ther (2002) 0.79
Amplicon vectors as outstanding tools to study and modify cognitive functions. Curr Gene Ther (2006) 0.79
Alteration of ribosomal protein maps in herpes simplex virus type 1 infection. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.79
Intracellular route and biological activity of exogenously delivered Rep proteins from the adeno-associated virus type 2. Virology (2005) 0.79
Glycoprotein D of bovine herpesvirus 5 (BoHV-5) confers an extended host range to BoHV-1 but does not contribute to invasion of the brain. J Virol (2010) 0.79
Herpes simplex virus type 1-derived recombinant and amplicon vectors. Methods Mol Biol (2011) 0.78
Immunological tolerance to muscle autoantigens involves peripheral deletion of autoreactive CD8+ T cells. PLoS One (2012) 0.78
HSV-1 amplicon vectors. Methods Enzymol (2002) 0.78
One giant genomic leap for gene transfer technology. Mol Ther (2003) 0.77
HSV-1 amplicon vectors as genetic vaccines. Methods Mol Biol (2014) 0.77
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1. J Virol (2004) 0.77
Viral and Cellular Components of AAV2 Replication Compartments. Open Virol J (2013) 0.77
HSV-1-derived helper-independent defective vectors, replicating vectors and amplicon vectors, for the treatment of brain diseases. Curr Opin Drug Discov Devel (2010) 0.77
Herpesviruses: balance in power and powers imbalanced. Vet Microbiol (2002) 0.77
Relative influence of the adeno-associated virus (AAV) type 2 p5 element for recombinant AAV vector site-specific integration. J Virol (2007) 0.77
Gene delivery using helper virus-free HSV-1 amplicon vectors. Curr Protoc Neurosci (2012) 0.77
Efficient and non-toxic gene transfer to cardiomyocytes using novel generation amplicon vectors derived from HSV-1. J Mol Cell Cardiol (2004) 0.77
Factors influencing helper-independent adeno-associated virus replication. Virology (2012) 0.77
Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors. Methods Mol Biol (2014) 0.76
Herpes simplex virus type 1 (HSV-1)-derived recombinant vectors for gene transfer and gene therapy. Methods Mol Biol (2015) 0.76
Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors for gene transfer and gene therapy. Methods Mol Biol (2015) 0.76